Search

Search Constraints

You searched for: Author/Creator Lopez-Tapia, Francisco

Search Results

1. A potent seven-membered cyclic BTK (Bruton's tyrosine Kinase) chiral inhibitor conceived by structure-based drug design to lock its bioactive conformation. Issue 9 (1st May 2019)

2. Novel potent azetidine-based compounds irreversibly inhibit Stat3 activation and induce antitumor response against human breast tumor growth in vivo. (28th May 2022)